Dorsey Wright & Associates Adverum Biotechnologies, Inc. Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$10.3 - $21.64 $7,642 - $16,056	-742 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$7.98 - $16.32 $5,921 - $12,109	742 New	742 $7,000
Q3 2019 Oct 31, 2019	SELL	$5.24 - $15.89 $6,225 - $18,877	-1,188 Closed	0 $0
Q2 2019 Jul 02, 2019	BUY	$5.1 - $11.89 $6,058 - $14,125	1,188 New	1,188 $14,000

2.53M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $748M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.